...
首页> 外文期刊>Psychoneuroendocrinology: An International Journal >Thyroid axis activity and serotonin function in major depressive episode.
【24h】

Thyroid axis activity and serotonin function in major depressive episode.

机译:重度抑郁发作时甲状腺轴活动和血清素功能。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Recent studies in depression have reported alterations in both hypothalamic-pituitary-thyroid (HPT) axis activity and serotonin (5-HT) function; however, the functional relationships between the two systems have not been well defined in patients with major depressive episode. Thyrotropin (TSH) response to 0800 and 2300 h protirelin (TRH) challenges, and adrenocorticotropic hormone (ACTH), cortisol, and prolactin (PRL) responses to D-fenfluramine (D-FEN), a specific 5-HT releasing/uptake-inhibiting agent, were examined in 60 drug-free DSM-IV major depressed inpatients and 20 hospitalized controls. Compared with controls, patients showed lower basal serum 2300 h TSH, 2300 h maximum increment in serum TSH above baseline (delta TSH) and difference between 2300 h delta TSH and 0800 h delta TSH (delta delta TSH) levels. The hormonal responses to D-FEN (i.e. delta ACTH, delta cortisol and delta PRL) were interrelated. No significant difference in basal and post-D-FEN ACTH, cortisol or PRL values were found between controls and patients. A negative relationship between hormonal responses to D-FEN and 2300 h delta TSH and delta delta TSH values was observed in the depressed group. When patients were classified on the basis of their delta TSH test status, patients with reduced delta delta TSH values (i.e. with HPT axis abnormality) had hormonal D-FEN responses comparable to those of controls. Patients with normal delta delta TSH values (i.e. without HPT axis abnormality) showed lower ACTH, cortisol and PRL responses to D-FEN than controls and patients with abnormal delta delta TSH values. These results suggest that: (1) pathophysiological mechanisms other than 5-HT dysregulation may be involved in TSH blunting in major depressed patients; (2) 5-HT function is reduced in some depressed patients, especially those without HPT axis abnormality; and (3) HPT dysregulation may be regarded as a compensatory mechanism for diminished central 5-HT activity.
机译:最近关于抑郁症的研究报道了下丘脑-垂体-甲状腺(HPT)轴活性和5-羟色胺(5-HT)功能的改变。然而,在患有严重抑郁发作的患者中,这两个系统之间的功能关系尚未得到很好的定义。促甲状腺素(TSH)对0800和2300 h普罗瑞林(TRH)挑战的反应,以及促肾上腺皮质激素(ACTH),皮质醇和催乳素(PRL)对D-芬氟拉明(D-FEN)的反应,一种特定的5-HT释放/摄取在60例无药物的DSM-IV重度抑郁症患者和20例住院对照中检查了这种抑制剂。与对照组相比,患者表现出较低的基础血清2300 h TSH,血清TSH高于基线的最大增量2300 h(δTSH),以及2300 h delta TSH和0800 h delta TSH(δTSH)之间的差异。 D-FEN的激素反应(即ACTHδ,皮质醇δ和PRLδ)相互关联。对照组和患者之间的基础和D-FEN ACTH,皮质醇或PRL值无显着差异。在抑郁组中,荷尔蒙对D-FEN的反应与2300 h delta TSH和delta delta TSH值之间呈负相关。当根据患者的TSH三角洲测试状态对患者进行分类时,ΔTSH值降低(即HPT轴异常)的患者的D-FEN激素反应与对照组相当。三角洲TSH值正常的患者(即无HPT轴异常)显示出对D-FEN的ACTH,皮质醇和PRL反应低于对照组和三角洲TSH值异常的患者。这些结果表明:(1)重度抑郁症患者的TSH钝化可能与5-HT失调有关。 (2)某些抑郁症患者,特别是那些没有HPT轴异常的患者,5-HT功能降低; (3)HPT失调可能被认为是中枢5-HT活性降低的补偿机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号